TW399050B - Process for the preparation of eprosartan - Google Patents
Process for the preparation of eprosartan Download PDFInfo
- Publication number
- TW399050B TW399050B TW087101969A TW87101969A TW399050B TW 399050 B TW399050 B TW 399050B TW 087101969 A TW087101969 A TW 087101969A TW 87101969 A TW87101969 A TW 87101969A TW 399050 B TW399050 B TW 399050B
- Authority
- TW
- Taiwan
- Prior art keywords
- patent application
- compound
- formula
- eprosartan
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3819597P | 1997-02-14 | 1997-02-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW399050B true TW399050B (en) | 2000-07-21 |
Family
ID=21898583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW087101969A TW399050B (en) | 1997-02-14 | 1998-04-15 | Process for the preparation of eprosartan |
Country Status (41)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100137613A1 (en) * | 2006-12-27 | 2010-06-03 | Hetero Drugs Limited | Process for eprosartan |
| WO2009013760A2 (en) * | 2007-07-25 | 2009-01-29 | Hetero Drugs Limited | Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan |
| EP2295431A3 (en) * | 2007-07-25 | 2011-08-03 | Hetero Drugs Limited | Substantially pure eprosartan free base |
| WO2009084028A2 (en) * | 2007-12-03 | 2009-07-09 | Neuland Laboratories Ltd | Improved process for manufacturing anhydrous (e)-3-[2-butyl-1- {(4-carboxyphenyl) methyl}-1h-imidazole-5-yl]-(thiophen-2- ylmethyl)prop-2-enoic acid methane sulfonate |
| CN101215284B (zh) * | 2007-12-31 | 2010-10-13 | 浙江华海药业股份有限公司 | 一种改进的依普罗沙坦的制备方法 |
| EP2257540A2 (en) * | 2008-03-31 | 2010-12-08 | Hetero Research Foundation | Improved process for eprosartan intermediate |
| WO2010023688A2 (en) * | 2008-08-25 | 2010-03-04 | Matrix Laboratories Limited | An improved process for the preparation of eprosartan |
| WO2011004384A2 (en) | 2009-06-05 | 2011-01-13 | Glochem Industries Limited | Process for the preparation of eprosartan |
| WO2011051975A1 (en) | 2009-10-30 | 2011-05-05 | Matrix Laboratories Ltd | An improved process for the preparation of pure eprosartanand its pharmaceutical acceptable salts |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5185351A (en) * | 1989-06-14 | 1993-02-09 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
| NZ239161A (en) * | 1990-07-31 | 1994-01-26 | Smithkline Beecham Corp | Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments, |
| EP0563238B1 (en) * | 1990-12-14 | 2002-05-22 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids |
| US5395847A (en) * | 1993-12-02 | 1995-03-07 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids |
| BR9507668A (pt) * | 1994-05-20 | 1997-10-07 | Smithkline Beecham Corp | Intermédio para preparar um composto farmaceuticamente atívo |
-
1998
- 1998-02-10 AR ARP980100585A patent/AR011125A1/es active IP Right Grant
- 1998-02-11 EG EG15598A patent/EG23935A/xx active
- 1998-02-12 MY MYPI98000577A patent/MY118704A/en unknown
- 1998-02-12 PE PE1998000101A patent/PE59299A1/es not_active Application Discontinuation
- 1998-02-12 MA MA24961A patent/MA24470A1/fr unknown
- 1998-02-12 IN IN360DE1998 patent/IN187999B/en unknown
- 1998-02-13 US US09/355,185 patent/US6172237B1/en not_active Expired - Lifetime
- 1998-02-13 EA EA199900740A patent/EA001659B1/ru not_active IP Right Cessation
- 1998-02-13 CO CO98007700A patent/CO4950550A1/es unknown
- 1998-02-13 DK DK98906229T patent/DK0970073T3/da active
- 1998-02-13 NZ NZ337180A patent/NZ337180A/xx unknown
- 1998-02-13 AT AT98906229T patent/ATE280765T1/de active
- 1998-02-13 AP APAP/P/1999/001620A patent/AP1128A/en active
- 1998-02-13 CA CA002281708A patent/CA2281708C/en not_active Expired - Fee Related
- 1998-02-13 JP JP52813798A patent/JP4537499B2/ja not_active Expired - Fee Related
- 1998-02-13 IL IL13130998A patent/IL131309A/en not_active IP Right Cessation
- 1998-02-13 CZ CZ0285299A patent/CZ296349B6/cs not_active IP Right Cessation
- 1998-02-13 PL PL335075A patent/PL192838B1/pl unknown
- 1998-02-13 SK SK1087-99A patent/SK285036B6/sk not_active IP Right Cessation
- 1998-02-13 ES ES98906229T patent/ES2231963T3/es not_active Expired - Lifetime
- 1998-02-13 RO RO99-00885A patent/RO119719B1/ro unknown
- 1998-02-13 ID IDW990839A patent/ID23181A/id unknown
- 1998-02-13 AU AU61508/98A patent/AU730383B2/en not_active Ceased
- 1998-02-13 BR BR9808664-2A patent/BR9808664A/pt not_active IP Right Cessation
- 1998-02-13 KR KR1019997007273A patent/KR100573638B1/ko not_active IP Right Cessation
- 1998-02-13 TR TR1999/01936T patent/TR199901936T2/xx unknown
- 1998-02-13 ZA ZA981207A patent/ZA981207B/xx unknown
- 1998-02-13 WO PCT/US1998/002412 patent/WO1998035963A1/en active IP Right Grant
- 1998-02-13 DE DE69827240T patent/DE69827240T2/de not_active Expired - Lifetime
- 1998-02-13 CN CN98802484A patent/CN1085208C/zh not_active Expired - Fee Related
- 1998-02-13 HU HU0001994A patent/HU228781B1/hu not_active IP Right Cessation
- 1998-02-13 EP EP98906229A patent/EP0970073B1/en not_active Expired - Lifetime
- 1998-02-13 PT PT98906229T patent/PT970073E/pt unknown
- 1998-02-13 UA UA99084635A patent/UA54487C2/uk unknown
- 1998-02-13 SI SI9830722T patent/SI0970073T1/xx unknown
- 1998-04-15 TW TW087101969A patent/TW399050B/zh not_active IP Right Cessation
- 1998-05-24 SA SA98190082A patent/SA98190082B1/ar unknown
-
1999
- 1999-08-10 BG BG103650A patent/BG63804B1/bg unknown
- 1999-08-13 NO NO19993913A patent/NO317194B1/no not_active IP Right Cessation
- 1999-08-13 OA OA9900179A patent/OA11146A/en unknown
-
2002
- 2002-01-28 IN IN58DE2002 patent/IN192743B/en unknown
-
2006
- 2006-04-07 CY CY0600011A patent/CY2555B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6927224B2 (en) | Selective estrogen receptor modulators | |
| TW399050B (en) | Process for the preparation of eprosartan | |
| US7902377B2 (en) | Method for preparing medetomidine and its salts | |
| CN1447789A (zh) | 治疗阿尔茨海默氏症的化合物 | |
| CN102307845B (zh) | 盐酸西那卡塞特的制备方法 | |
| CN113185451A (zh) | 美金刚脲类衍生物及其制备方法和应用 | |
| LU84562A1 (fr) | 2-(4-((4,4-dialcoyl-2,6-piperidinedione-1-yl)butyl)-1-piperazinyl)pyridines | |
| TW438746B (en) | New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions | |
| JPS5826883A (ja) | ６−｛４−〔ω−（１−イミダゾリル）−アルキル〕−フエニル｝−３−オキソ−２，３，４，５−テトラヒドロ−ピリダジン化合物 | |
| JPH07502519A (ja) | 新規１−（アリールアルキルアミノアルキル）イミダゾール化合物 | |
| US8937184B2 (en) | 1H-imidazole derivatives as cannabinoid CB2 receptor modulators | |
| CN109666023B (zh) | 一种尼洛替尼的制备方法及其中间体 | |
| US11639326B2 (en) | Continuous flow synthesis of ibuprofen | |
| JPH06758B2 (ja) | イミダゾール誘導体、その製法およびそれを含有する医薬 | |
| TWI234562B (en) | Process for preparing 1,5-diaryl-3-substituted pyrazoles | |
| CN101107233A (zh) | 作为大麻素cb2受体调节剂的1h－咪唑衍生物 | |
| US6194585B1 (en) | Process for preparing 5-lipoxygenase inhibitors | |
| US7176223B2 (en) | Method for synthesis of 5-(3-pyridylmethylene-)imidazolidine-2,4-dione | |
| US3595866A (en) | 1-amino-3-aminoalkyl-3-phenyloxindole-compounds | |
| JPS60204750A (ja) | ＤＬ‐β‐アリールアミノ酸の調製方法 | |
| JP5807423B2 (ja) | ナフトピジルの製造方法 | |
| US20100145064A1 (en) | Method for the preparation of zolmitriptan | |
| JPS59161343A (ja) | ４−アミノ酪酸誘導体及びその製法 | |
| JP2001064265A (ja) | アルキルヒダントイン類 | |
| FR2921063A1 (fr) | Ligands des recepteurs cannabinoides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GD4A | Issue of patent certificate for granted invention patent | ||
| MM4A | Annulment or lapse of patent due to non-payment of fees |